Pancrelipase
Links shared publicly online about this topic
Medical News: FDA Formally Approves Creon Pancrelipase - in Product Alert, Prescriptions from MedPage Today
medpagetoday.com — “SAN FRANCISCO -- The FDA has approved the Creon brand of delayed-release pancrelipase for treatment of exocrine pancreatic insufficiency.” View full resource at medpagetoday.com
Most Recently Shared on May 1, 2009 at 6:56 pm By:
FDA Formally Approves Pancrelipase http://medpagetoday.com/14021
CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatitis
medicalnewstoday.com — “Solvay Pharmaceuticals, Inc. announced that new data demonstrate that CREON®( )(pancrelipase) Delayed-Release Capsules significantly improves a key measure of fat absorption in adults with exo” View full resource at medicalnewstoday.com
Most Recently Shared on October 27, 2009 at 11:14 am By:
MNT Clinical Trials Health News
CREON(R) (pancrelipase) Delayed-Release Capsules Improves Digestive Outcomes In Adults With Chronic Pancreatiti.. http://bit.ly/AjVpS
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreatic Insufficiency
medicalnewstoday.com — “Abbott (NYSE: ABT) announced that the U.S. Food and Drug Administration (FDA) has approved an infant-specific dose of CREON® (pancrelipase) Delayed-Release Capsules to treat exocrine pancreati” View full resource at medicalnewstoday.com
Most Recently Shared on June 16, 2011 at 7:05 am By:
MNT Cystic Fibrosis Health News
Abbott Receives FDA Approval For CREON® (Pancrelipase) Infant-Specific Dosage For Patients With Exocrine Pancreati... http://mnt.to/3XfN
Abbott Japan And Eisai Receive Approval To Market The Pancreatic Digestive Enzyme Replacement Drug Lipacreon(R) (pancrelipase) In Japan
medicalnewstoday.com — “Abbott Japan Co., Ltd. and Eisai Co., Ltd. (TSE: 4523) announced today that they have received approval to market the pancreatic enzyme replacement drug Lipacreon(R)(pancrelipase) in Japan as a pa” View full resource at medicalnewstoday.com
Most Recently Shared on April 26, 2011 at 12:05 pm By:
MNT Cystic Fibrosis Health News
Abbott Japan And Eisai Receive Approval To Market The Pancreatic Digestive Enzyme Replacement Drug Lipacreon(R) (pancr... http://mnt.to/3V2Y
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 14, 2011 at 11:36 pm By:
FDA Approves Creon (pancrelipase) Infant-Specific Dosage Strength - http://bit.ly/jAdfb4
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pancreatic Insufficiency Due to Cystic Fibrosis
drugs.com — “Creon (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Creon side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on June 15, 2011 at 12:08 am By:
Drugs and Devices OW OW Health
Abbott Receives FDA Approval for Creon (pancrelipase) Infant-Specific Dosage for Patients With Exocrine Pa... http://bit.ly/kZWxyW #drug
Results Published In Journal Of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improves Fat Absorption
medicalnewstoday.com — “Solvay Pharmaceuticals, Inc. announced that Phase III data published in the Journal of Cystic Fibrosis showed that CREON® (pancrelipase) Delayed-Release Capsules, the most prescribed pancreati” View full resource at medicalnewstoday.com
Most Recently Shared on October 10, 2009 at 1:01 pm By:
MNT Clinical Trials Health News
Results Published In Journal Of Cystic Fibrosis Confirm CREON(R) (pancrelipase) Delayed-Release Capsules Improv.. http://bit.ly/aOdtA
CREON(R) (pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption In Children With Cystic Fibrosis
medicalnewstoday.com — “Solvay Pharmaceuticals, Inc. announced that Phase IIIb data published in the January issue of Clinical Therapeutics confirm that CREON® (pancrelipase) Delayed-Release Capsules significantly im” View full resource at medicalnewstoday.com
Most Recently Shared on February 6, 2010 at 3:05 pm By:
MNT Clinical Trials Health News
CREON(R) (pancrelipase) Delayed-Release Capsules Significantly Improves Fat Absorption In Children With Cystic Fibrosis http://mnt.to/3xjV
Abbott Japan and Eisai Announce Launch of Pancreatic Digestive Enzyme Replacement Drug Lipacreon (pancrelipase) - Drugs.com MedNews
drugs.com — “Abbott Japan Co., Ltd. (Pharma Products Group Headquarters Tokyo, President Gary M. Winer) and Eisai Co., Ltd. (Headquarters Tokyo, President CEO Haruo Naito) a” View full resource at drugs.com
Most Recently Shared on August 29, 2011 at 1:07 pm By:
Drugs and Devices OW OW Health
Abbott Japan and Eisai Announce Launch of Pancreatic Digestive Enzyme Replacement Drug Lipacreon (pancreli... http://t.co/sql0fa0 #drug
Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exocrine Pancreatic Insufficiency in Cystic Fibrosis
hindawi.com — “Background. Pancreatic enzyme replacement therapy is the standard of care for treatment of malabsorption in patients with cystic fibrosis (CF) and exocrine pancreatic insufficiency (PI). Aim. To evaluate efficacy and safety of a new formulation of pancrelipase (Ultrase MT20) in patients with CF and PI. Coefficients of fat absorption (CFA%) and nitrogen absorption (CNA%) were the main efficacy parameters. Safety was evaluated by monitoring laboratory analyses, adverse events (AEs), and overall si” View full resource at hindawi.com
Most Recently Shared on December 9, 2010 at 9:39 pm By:
Efficacy and Safety of a New Formulation of Pancrelipase (Ultrase MT20) in the Treatment of Malabsorption in Exo... http://bit.ly/ifrhbg
Eurand Granted FDA Approval for Zenpep
drugs.com — “Zenpep (pancrelipase) is used to treat exocrine pancreatic insufficiency. Includes Zenpep side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on August 29, 2009 at 7:33 pm By:
Eurand Granted FDA Approval for Zenpep - http://bit.ly/3I6xA6
Abbott Receives FDA Approval For CREON(R) To Include Dosing Information For Patients With Chronic Pancreatitis And Pancreatectomy
medicalnewstoday.com — “Abbott today announced that the U.S. Food and Drug Administration (FDA) approved the supplemental New Drug Application (sNDA) for CREON® (pancrelipase) Delayed-Release Capsules that now includ” View full resource at medicalnewstoday.com
Most Recently Shared on May 5, 2010 at 12:19 pm By:
MNT Drug Approvals Health News
Abbott Receives FDA Approval For CREON(R) To Include Dosing Information For Patients With Chronic Pancreatitis And Pan... http://mnt.to/3C8g
FDA approves two new pancreatic enzyme products to aid food digestion
fda.gov — “Two new pancreatic enzyme products used to help aid food digestion, Ultresa (pancrelipase) and Viokace (pancrelipase), were approved today by the U.S. Food and Drug Administration.” View full resource at fda.gov
Most Recently Shared on March 1, 2012 at 5:13 pm By:
Bernard Farrell Patient Expert
RT @sstrumello: FDA approves two new pancreatic enzyme products to aid food digestion http://t.co/1AoAlwuh
Eurand Announces Data On Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEPs To FDA-Approved ZENPEP(R)
medicalnewstoday.com — “Eurand Pharmaceuticals, Inc., a subsidiary of global specialty pharmaceutical company Eurand N.V. (NASDAQ: EURX), announced additional data from a post-hoc analysis of a Phase III clinical trial w” View full resource at medicalnewstoday.com
Most Recently Shared on June 18, 2010 at 10:34 am By:
MNT Cystic Fibrosis Health News
Eurand Announces Data On Switching Cystic Fibrosis Patients With Exocrine Pancreatic Insufficiency From Unapproved PEP... http://mnt.to/3F2Z
Cystic Fibrosis Foundation Launches National Cycling Series To Benefit Critical Research And Care
medicalnewstoday.com — “Thousands of cyclists will take to the streets this summer and fall as the Cystic Fibrosis Foundation launches a new cycling tour in 18 cities across the country to support research to find new th” View full resource at medicalnewstoday.com
Most Recently Shared on May 5, 2010 at 7:21 am By:
MNT Cystic Fibrosis Health News
Cystic Fibrosis Foundation Launches National Cycling Series To Benefit Critical Research And Care http://mnt.to/3C7Z #cysticfibrosis
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
MedPage Today
Daily, peer reviewed medical news for clinicians
-
MNT Clinical Trials
The latest clinical trials news published daily. Articles from research centers, universities and prestigious journals.
-
MNT Cystic Fibrosis
The latest cystic fibrosis news published daily. Articles from research centers, universities and prestigious journals.
Advertisement
